Biologics in asthma: do we need so many and who do we miss?

Year in review
Aims: to summarize the immunology of asthma, the cytokines or receptors currently targeted, the possible mechanisms of sub-optimal responses, and the importance of determining the immune make-up of individual patients prior to prescribing mAb therapy, in the age of precision medicine for asthma.

Biologics in asthma: do we need so many and who do we miss? G. Brusselle (Ghent, Belgium)